Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
The emerging link between hypogonadism and metabolic syndrome Guay ATJ Androl 2009[Jul]; 30 (4): 370-6The metabolic syndrome (MS) is comprised of various medical conditions that confer increased risk of diabetes and cardiovascular disease. The pathophysiologic components of MS include glucose abnormality, obesity or increased waist circumference, increased blood pressure, and hyperlipidemia. There is an increased risk of hypogonadism in men with MS and its individual components, including insulin resistance, considered by some to be at the core of MS. Hypogonadism may even predict MS. These factors are interwoven and impact overall health, including sexual dysfunction. One interesting and important question is whether treating hypogonadism with testosterone replacement will ameliorate the pathological components of MS.|Cardiovascular Diseases[MESH]|Diabetes Mellitus, Type 2/complications[MESH]|Erectile Dysfunction/complications[MESH]|Humans[MESH]|Hypogonadism/*complications/drug therapy[MESH]|Insulin Resistance[MESH]|Male[MESH]|Metabolic Syndrome/*complications[MESH]|Obesity/complications[MESH]|Risk Factors[MESH]|Testosterone/therapeutic use[MESH] |
